Managed Pharmaceutical Markets

The managed care model has seen huge growth in the pharmaceutical industry. It is estimated that in the US, 85% of all prescription drugs are today reimbursed through a managed care plan. In order to ensure preferred and profitable access of drugs in the marketplace, bridging the information and deriving insights across market access, reimbursements, payer relationships, physician influence and physical preferences is critical. All pharmaceutical and medical device companies require analytics, decision supporting systems, and processes to maintain competitive advantages in managing the contract lifecycle while supporting the pricing mechanism (i.e., minimizing revenue leakage) and regulatory requirements needs imposed by various government agencies.

  • Claims Reporting
  • Managed Care Landscape
  • Pricing and Reimbursement Analysis
  • Cost-Benefit Analysis
  • Health Economics and Outcomes Research
  • Compliance and Persistence Studies

Request A Call Back !